he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查看复用地址
下一页:青少年得癫痫病的性疾病是什么
- 2022-05-10著名医学家、瑞金医院终身大学教授陈家伦逝世,享年93岁
- 2022-05-04Sci Adv:帕金森氏症、癌症、2型糖尿病“三兄弟”原是承传
- 2022-04-212013年国际抗癫痫该协会抗癫痫药使用指南
- 2022-03-28膀胱炎的症状 有四种症状。小心膀胱炎在路上
- 2022-03-15著名女演员愤怒地告诉莆田妇科医院 要求在全国媒体上公开道歉
- 2022-02-21癫痫病治疗后需要多久能中风
- 月经前肿痛的原因是什么?
- 抗癫痫药物预防新发癫痫:任重而道远
- 乳腺增生结节疏通茶 | 改善月经前胀痛
- 疾病新知:毛囊性白癜风
- 胀痛发生了什么事?
- 自身免疫病也可以免疫治疗
- 银屑病常用药物进入医疗保险,有效减轻患者的医疗负担
- 小妹妹一股异味怎么了?
- BMC Urol:晚期癌症患者服用阿帕鲁胺后出现皮疹需要特殊治疗吗?
- 月经期间要注意 有些药物和食物不能食用
- 为什么身上有小白点 可能得了这种病?
- 女生有妇科炎症,能自愈吗?
- 膀胱炎的症状 有四种症状。小心膀胱炎在路上
- 前庭腺囊肿
- 月经前后疼痛?这样的乳腺增生严重吗?
- 丁香园通讯员与钱荣立教授简短交流
- 北京妇产医院首都医科大学第九届妇科内镜技术手拉手培训班
- 母乳┃哺乳期母亲如何避免乳腺炎?
- 月经前兆 教你正确处理月经
- DDS:在质子泵抑制剂中添加阿托品可有效治疗非侵蚀性反流病患者的难治症状
- 23一岁女孩的大腿骨溶解是因为鬼骨在作怪?
- 著名女演员愤怒地告诉莆田妇科医院 要求在全国媒体上公开道歉
- 轻度癫痫的症状是什么?
- 研究发现,置入支架接近手术打开动脉的再堵塞风险
- 厕所会对健康造成这样的伤害
- 染发的危害 这样做可能会导致脱发
- GUT:微生物群的转移减少了阿尔茨海默病动物模型中脑淀粉样变性
- 白癜风症状 身体出现白斑时要小心
- 磨牙是没事 如何有效预防磨牙
- 癫痫病的病征到底是什么
- 癫痫病症状 怎样诊疗癫痫病人
- 治疗癫痫病处方要怎么治疗好啊
- 56个药被点名,涉一批药企:恒瑞、石药、长河…
- 迈瑞、瑞普等大企业重点中轴,新瑞鹏融资额领跑,宠物医疗迎来爆发丨2020年度盘点
- 研究称猪肉绦虫患者的癫痫由p液体引起
- 癫痫病发病究竟是干什么
- “药不能停”!擅自服药,癫痫频繁发作
- 不注意这些问题,吃到多少药都没用!
- 罗氏制药面世致医生信警示甲氟喹的神经精神不良反应
- Diabetes Obes Metab:恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾一集的关系